GSK Investigational Site
Uttoxeter ST14 5JX
0 studies enrolling now · 1 studies all time
What they study most
Asthma
Studies at this site
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
— Completed